AI Article Synopsis
- HIV-infected children often experience weight and height growth impairments, which can indicate disease progression and increase the risk of death.
- A non-systematic review of relevant literature from PubMed shows that antiretroviral therapy (ART) substantially reduces illness and mortality rates in these children, particularly when administered early.
- Overall, ART leads to significant improvements in weight and height measurements among HIV-infected children, although further research on growth treatment strategies is ongoing.
Article Abstract
Objective: Weight and height growth impairment is one of the most frequent manifestations in HIV-infected children and may be the first sign of disease, being considered a marker of disease progression and an independent risk factor for death. The aim of this review is to evaluate the influence of antiretroviral therapy on the growth pattern of children and adolescents living with HIV/AIDS.
Source Of Data: A non-systematic review was carried out in the PubMed database, with the terms "HIV", "Weight and height growth", "ART" and "children". The most relevant publications were selected.
Data Synthesis: Antiretroviral therapy has significantly reduced morbidity and mortality in HIV-infected children and is clearly associated with recovery of weight and height-for-age Z-scores, especially when started early, in the asymptomatic child still without weight-height impairment. Therapeutic strategies involving the GH/IGF-1 axis, especially for children with growth impairment, are still being studied.
Conclusions: HIV-infected children show early weight-height impairment; antiretroviral therapy improves the anthropometric profile of these children.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jped.2018.12.007 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!